CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
ZGFAX
Price
$18.94
Change
+$0.08 (+0.42%)
Updated
Jul 13 closing price
Net Assets
349.53M
Interact to see
Advertisement

CNPAX vs ZGFAX

CNPAX vs ZGFAX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. ZGFAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and ZGFAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. ZGFAX (350M). CNPAX pays higher dividends than ZGFAX: CNPAX (0.95) vs ZGFAX (0.73). CNPAX was incepted earlier than ZGFAX: CNPAX (24 years) vs ZGFAX (8 years). ZGFAX (0.86) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. ZGFAX (14.00). CNPAX has a lower initial minimum investment than ZGFAX: CNPAX (250) vs ZGFAX (100000). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. ZGFAX (-2.78). ZGFAX return over 5 years is better than : 19.08 vs. CNPAX (13.82).
CNPAXZGFAXCNPAX / ZGFAX
Total Expense Ratio0.740.8686%
Annual Report Gross Expense Ratio0.740.8686%
Fund Existence24 years8 years-
Gain YTD5.325-1.457-366%
Front Load4%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets170B350M48,571%
Annual Yield % from dividends0.950.73131%
Returns for 1 year7.37-2.78-265%
Returns for 3 years34.1721.92156%
Returns for 5 years13.8219.0872%
Returns for 10 years115.91N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6